Tango Therapeutics(TNGX) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR Washington, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO FORM 10-K Commission File Number 001-39485 TANGO THERAPEUTICS, INC. (Exact name of Registrant as specified in its Charter) (Mark One) Delaware 85-1195036 (State or other jurisdiction of incorporation or organization) 100 Binney St., Suite 700 Cambridge, MA 02142 (Address of principal executive offices) (Zip Cod ...